ArticleMolecular cytogenetics2026
Antenatal discovery of mosaic trisomy 14 in an early-onset malformative syndrome.
Article in Molecular cytogenetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Trisomy 14 mosaicism is a rare chromosomal disorder caused by the presence of an extra chromosome 14 in a subset of cells. Its true prevalence is unclear due to frequent early pregnancy loss. Clinical manifestations vary widely and include fetal growth restriction, craniofacial dysmorphia, cardiac and genitourinary anomalies, with no consistent correlation between mosaicism level and severity. We report a case of prenatal trisomy 14 mosaicism diagnosed via chorionic villus sampling and confirmed in fetal tissue. Ultrasound at 15 weeks showed multiple congenital anomalies affecting the craniofacial region, heart, and limbs , along with growth restriction. Given the severity, termination of pregnancy was performed at 17 weeks. Postmortem examination confirmed the anomalies, including abnormal male external genitalia. FISH analysis on muscle tissue demonstrated trisomy 14 mosaicism in approximately 35% of nuclei. This case contributes to the limited prenatal literature on trisomy 14 mosaicism and emphasizes the value of early imaging and cytogenetic analysis in diagnosis and counselling. It highlights the importance of concurrent detailed early sonographic evaluation and targeted cytogenetic testing in suspected malformative syndromes, as well as the diagnostic value of postmortem tissue-specific FISH to better characterize the mosaic distribution. Because mosaicism levels may vary markedly between tissues and do not necessarily correlate with phenotypic severity, this case also illustrates the limitations of chorionic villus sampling and amniocentesis, and supports multi-tissue sampling in fetopathological assessment to refine prognostic evaluation and genetic counselling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.